ATSDR’s Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : July 22-23, 2015 summary meeting
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

ATSDR’s Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : July 22-23, 2015 summary meeting

Filetype[PDF-3.58 MB]


  • English

  • Details:

    • Description:
      Due to the limited information on the unknown cause(s) of Amyotrophic Lateral Sclerosis (ALS), the Agency for Toxic Substances and Disease Registry (ATSDR) established the National ALS Registry in 2010. The primary purpose of the ALS Registry is to describe the incidence and prevalence of ALS, to describe the demographics of ALS patients, and to examine the risk factors for the disease. In 2014, the ALS Registry published their first report on the prevalence of ALS in the United States in CDC’s Morbidity and Mortality Weekly Report (MMWR). In addition, ATSDR has published/supported publication of over two dozen journal articles relating to a number of ALS topics including, but not limited to, incidence and prevalence findings in three states and eight metropolitan areas, demographics of those living with the disease, selected potential risk factors for ALS, and recruitment for ALS research through the National ALS Registry.

      ATSDR organizes the Annual ALS Surveillance Meeting to update stakeholders on the progress of the National ALS Registry, the Registry data and its implication, and to discuss strategies to further enhance the Registry for all of the stakeholders. In 2016, the National ALS Biorepository will be initiated with the primary goal of providing the largest bank of ALS blood and tissue samples in the US.

      Publication date from document properties.

    • Document Type:
    • Place as Subject:
    • Main Document Checksum:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov